-
FDA approves COVID-19 antiviral Xocova as PEP. But will it be accessible?
Shionogi, the Japanese company that makes Xocova (ensitrelvir), said the post-exposure prophylaxis drug will be available in mid-July in the U.S. and will have a list price of $1,400. But its impact will hinge on how easily people can access it, experts say. Read more…
Recent articles
Get the latest Long COVID news and commentary
Processing…
Success! You're on the list.
Whoops! There was an error and we couldn't process your subscription. Please reload the page and try again.
Check out our weekly podcast, Still Here
Spotify
Apple Podcasts
PocketCasts
iHeartRadio
RSS
Policy & Advocacy
-
Federal workers with Long COVID face firings, loss of accommodations, and more challenges under Trump
-
Trump commands HHS to terminate advisory committee on Long COVID
-
Now offline: Government resources about Long COVID as a disability
-
Breaking: Vital Long COVID data taken down following Trump order
-
RECOVER hasn’t been impacted by Trump freezes so far, sources say. But the program’s future is still uncertain.
-
Some U.S. COVID-19 data are down amid “pause” to federal health communications
Science
-
Research updates, November 11
-
Research updates, November 4
-
We need more at-home clinical trials for Long COVID. Here’s how we designed the largest one yet.
-
Metformin has been shown to reduce the risk of Long COVID. Why isn’t it more widely used?
-
Research updates, October 28
-
Research updates, October 21
Covid-19
Health
-
Priced out: Some Long COVID and ME specialists charge high prices for concierge care
-
UNC shuts down Long COVID clinic, leaving thousands without specialized care
-
The federal government is restricting COVID-19 vaccine access. Here’s what that means for the ongoing pandemic and people with Long COVID.
-
Long COVID is increasing housing insecurity, but support programs fail to help
-
Churches are ignoring the Long COVID crisis. Some say it’s at odds with Christian values.
-
Los Angeles’ $13M COVID-19 relief funds could go to building upgrades, not Long COVID care
-
Long COVID data are being erased, again
-
A serendipitous friendship taught me my greatest lesson in living with Long COVID: How to just be
-
The sick soft butch who did: How confronting a racist in my neighborhood helped me claim my Long COVID identity
-
Our community came together to start International Long COVID Awareness Day in 2023. Here’s how you can get involved this year.